NCT00359736View on ClinicalTrials.gov

Sildenafil Study to Treat Idiopathic Pulmonary Fibrosis

PHASE2CompletedINTERVENTIONAL
Enrollment

29

Participants

Timeline

Start Date

July 31, 2006

Primary Completion Date

October 31, 2008

Study Completion Date

June 30, 2009

Conditions
Alveolitis, FibrosingFibrosis, PulmonaryHypertension, Pulmonary
Interventions
DRUG

sildenafil

Assessing the possible therapeutic benefit of sildenafil on exercise tolerance in IPF patients.

Trial Locations (1)

33125

VA Medical Center, Miami, Miami

All Listed Sponsors
lead

VA Office of Research and Development

FED

NCT00359736 - Sildenafil Study to Treat Idiopathic Pulmonary Fibrosis | Biotech Hunter | Biotech Hunter